| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/S0140-6736(97)90025-8 |
| P698 | PubMed publication ID | 9250280 |
| P2093 | author name string | R S Scott | |
| M W Webster | |||
| P2860 | cites work | Early atherosclerosis is retarded by improved long-term blood glucose control in patients with IDDM | Q71442189 |
| Cholesterol-lowering therapy may retard the progression of diabetic nephropathy | Q71564786 | ||
| Association between QT dispersion and autonomic dysfunction in patients with diabetes mellitus | Q71745699 | ||
| NIDDM and its metabolic control predict coronary heart disease in elderly subjects | Q72080013 | ||
| Coronary artery disease and coronary artery bypass grafting in diabetic patients aged > or = 65 years (report from the Coronary Artery Surgery Study [CASS] Registry) | Q72127531 | ||
| Effects of beta blockers (atenolol or metoprolol) on heart rate variability after acute myocardial infarction | Q72127534 | ||
| Uniformity of captopril benefit in the SAVE Study: subgroup analysis. Survival and Ventricular Enlargement Study | Q72164104 | ||
| Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial | Q72198055 | ||
| Meta-analysis of effects of intensive blood-glucose control on late complications of type I diabetes | Q72218722 | ||
| The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus | Q72340287 | ||
| Primary nitrate tolerance in diabetes mellitus | Q72345782 | ||
| Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year | Q72351090 | ||
| Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty | Q72533103 | ||
| Silent myocardial ischemia: role of subclinical neuropathy in patients with and without diabetes | Q72573684 | ||
| Effect of autonomic nervous system dysfunction on the circadian pattern of myocardial ischemia in diabetes mellitus | Q72726510 | ||
| Effects of antihypertensive therapy on serum lipids | Q72889299 | ||
| Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S) | Q73209707 | ||
| The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group | Q27861088 | ||
| Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators | Q28281001 | ||
| Diabetic and hypertensive heart disease | Q28283151 | ||
| The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators | Q29547887 | ||
| Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration | Q29619529 | ||
| Reduction of lower extremity clinical abnormalities in patients with non-insulin-dependent diabetes mellitus. A randomized, controlled trial | Q34365462 | ||
| Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study | Q34720231 | ||
| Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group | Q36244558 | ||
| Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia. A serial intravascular ultrasound study | Q36856232 | ||
| Effect of cardioselective and non-selective beta-blockade on the hypoglycaemic response in insulin-dependent diabetics | Q39534682 | ||
| Diabetes mellitus and associated hypertension, vascular disease, and nephropathy. An update | Q40376712 | ||
| Beta-blockers and sudden cardiac death. | Q40454258 | ||
| Bilateral mammary artery grafting: avoidance of complications with extended use. | Q40713531 | ||
| Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VII. Mortality and selected nonfatal events with insulin treatment | Q40901830 | ||
| Potential mechanisms promoting restenosis in diabetic patients | Q40973029 | ||
| Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study | Q41840439 | ||
| Managing diabetes after myocardial infarction | Q42783712 | ||
| Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial | Q44459441 | ||
| Thromboxane biosynthesis and platelet function in type II diabetes mellitus | Q45056796 | ||
| Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group | Q46581479 | ||
| Calcium antagonists and mortality in patients with coronary artery disease: a cohort study of 11,575 patients. | Q51017152 | ||
| Lipids, diabetes, and coronary heart disease: insights from the Framingham Study. | Q53841061 | ||
| Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients | Q54066813 | ||
| Angiographic Findings and Outcome in Diabetic Patients Treated With Thrombolytic Therapy for Acute Myocardial Infarction: The GUSTO-I Experience | Q56945225 | ||
| Metaiodobenzylguanidine imaging in diabetes mellitus: Assessment of cardiac sympathetic denervation and its relation to autonomic dysfunction and silent myocardial ischemia | Q57485157 | ||
| A study of the effects of hypoglycemia agents on vascular complications in patients with adult-onset diabetes. VI. Supplementary report on nonfatal events in patients treated with tolbutamide | Q67864944 | ||
| Autonomic neuropathy, QT interval lengthening, and unexpected deaths in male diabetic patients | Q67963458 | ||
| Aspirin effects on mortality and morbidity in patients with diabetes mellitus. Early Treatment Diabetic Retinopathy Study report 14. ETDRS Investigators | Q68021310 | ||
| The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group | Q70513402 | ||
| Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis | Q70520152 | ||
| Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry | Q71111986 | ||
| Usefulness of beta-blocker therapy in patients with non-insulin-dependent diabetes mellitus and coronary artery disease. Bezafibrate Infarction Prevention (BIP) Study Group | Q71181134 | ||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | SI23-8 | |
| P577 | publication date | 1997-07-01 | |
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | What cardiologists need to know about diabetes | |
| P478 | volume | 350 Suppl 1 |
| Q35073040 | Carotid intima media thickness as a measure of cardiovascular disease burden in nigerian africans with hypertension and diabetes mellitus |
| Q34721194 | Carotid intima-media thickness as a surrogate marker of cardiovascular disease in diabetes |
| Q35131648 | Comparison of the hospital arrival time and differences in pain quality between diabetic and non-diabetic STEMI patients. |
| Q33762031 | Diabetes and ischemic heart disease |
| Q77943408 | Does bilateral internal thoracic artery grafting increase surgical risk in diabetic patients? |
| Q36133968 | Frequency of risk factors for coronary heart disease among diabetic patients in Al-rabwah phc center in riyadh |
| Q34455031 | Homocysteine and cardiovascular disease in diabetes mellitus |
| Q33582188 | Impact of double internal thoracic artery grafts on long-term outcomes in coronary artery bypass grafting |
| Q74143745 | Is diabetes mellitus a major risk factor in coronary artery bypass grafting? The influence of internal thoracic artery grafting on late survival in diabetic patients |
| Q74751614 | Left-ventricular dysfunction in diabetic patients with leucine tRNA mutation |
| Q64083675 | Metformin in patients with and without diabetes: a paradigm shift in cardiovascular disease management |
| Q34592089 | Pharmacologic treatment of the critically ill patient with diabetes |
| Q38081078 | Platelet function profiles in patients with diabetes mellitus |
| Q36620034 | Resveratrol ameliorates high-glucose-induced hyperpermeability mediated by caveolae via VEGF/KDR pathway |
| Q35115805 | Role of pro‐atherogenic adhesion molecules and inflammatory cytokines in patients with coronary artery disease and diabetes mellitus type 2 |
| Q95331560 | The HOPE study and diabetes. Heart Outcomes Prevention Evaluation |
| Q77683292 | The arterial organ in cardiovascular disease: ADAPT (arterial disease assessment, prevention, and treatment) clinic |
| Q46138167 | The effect of short-term, high glucose concentration on endothelial cells and leukocytes in a 3D in vitro human vascular tissue model |
Search more.